-
公开(公告)号:US11661593B2
公开(公告)日:2023-05-30
申请号:US14571670
申请日:2014-12-16
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor: Meinhard Hasslacher , Christian Fiedler , Christa Mayer , Artur Mitterer
CPC classification number: C12N9/6489 , C12M47/12 , C12N11/14 , C12Y304/24087
Abstract: Provided herein are methods for purifying recombinant A Disintegrin-like and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises enriching for ADAMTS13 protein by chromatographically contacting the sample with hydroxyapatite under conditions that allow ADAMTS13 protein to appear in the eluate or supernatant from the hydroxylapatite. The methods may further comprise tandem chromatography with a mixed mode cation exchange/hydrophobic interaction resin that binds ADAMTS13 protein. Additional optional steps involve ultrafiltration/diafiltration, anion exchange chromatography, cation exchange chromatography, and viral inactivation. Also provided herein are methods for inactivating virus contaminants in protein samples, where the protein is immobilized on a support. Also provided herein are compositions of ADAMTS13 prepared according to said methods.
-
公开(公告)号:US11299533B2
公开(公告)日:2022-04-12
申请号:US16015452
申请日:2018-06-22
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor: Meinhard Hasslacher , Martin Feichtinger , Philipp M. Bärnthaler , Christa Mayer , Birgit Reipert , Mantas Malisauskas , Julia Anzengruber
Abstract: The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
-
公开(公告)号:US12071468B2
公开(公告)日:2024-08-27
申请号:US17688588
申请日:2022-03-07
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor: Meinhard Hasslacher , Martin Feichtinger , Philipp M. Bärnthaler , Christa Mayer , Birgit Reipert , Mantas Malisauskas , Julia Anzengruber
CPC classification number: C07K14/755 , B01D15/327 , B01D15/34 , B01D15/363 , C07K1/16 , C07K1/18 , C07K1/36 , A61K38/00 , B01D15/363 , B01D15/34 , B01D15/363 , B01D15/327 , B01D15/34
Abstract: The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
-
公开(公告)号:US20230242897A1
公开(公告)日:2023-08-03
申请号:US18298742
申请日:2023-04-11
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor: Meinhard Hasslacher , Christian Fiedler , Christa Mayer , Artur Mitterer
CPC classification number: C12N9/6489 , C12Y304/24087 , C12N11/14 , C12M47/12
Abstract: Provided herein are methods for purifying recombinant A Disintegrin-like and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises enriching for ADAMTS13 protein by chromatographically contacting the sample with hydroxyapatite under conditions that allow ADAMTS13 protein to appear in the eluate or supernatant from the hydroxylapatite. The methods may further comprise tandem chromatography with a mixed mode cation exchange/hydrophobic interaction resin that binds ADAMTS13 protein. Additional optional steps involve ultrafiltration/diafiltration, anion exchange chromatography, cation exchange chromatography, and viral inactivation. Also provided herein are methods for inactivating virus contaminants in protein samples, where the protein is immobilized on a support. Also provided herein are compositions of ADAMTS13 prepared according to said methods.
-
公开(公告)号:US20220275058A1
公开(公告)日:2022-09-01
申请号:US17688588
申请日:2022-03-07
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor: Meinhard Hasslacher , Martin Feichtinger , Philipp M. Bärnthaler , Christa Mayer , Birgit Reipert , Mantas Malisauskas , Julia Anzengruber
Abstract: The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
-
-
-
-